Get Meibomian Gland Dysfunction Treatment Online

Meibomian gland dysfunction (MGD) occurs when the small oil glands along the eyelid margins become blocked or produce poor-quality secretions. This disrupts the lipid layer of the tear film, causing tears to evaporate too quickly. Common contributing factors include age, rosacea, blepharitis, contact lens use, low blinking rates associated with screen time, and certain systemic medications.

People with MGD often experience chronic dry, gritty, or burning eyes, eyelid margin redness or thickening, crusting or foamy discharge along the lashes, blurred vision that clears with blinking, and sensitivity to light. Symptoms are frequently worse in dry or windy environments and after prolonged screen use.

Diagnosis is typically based on symptoms and a clinical examination of the eyelid margins, looking for signs such as plugged gland openings, thickened secretions, and eyelid margin inflammation. Tear film evaluation and assessment of tear breakup time may also be used to gauge severity.

Prescription options include oral doxycycline for its anti-inflammatory effect on meibomian glands, topical cyclosporine (Restasis) or lifitegrast (Xiidra) eye drops to reduce ocular surface inflammation, and short-term topical corticosteroids in some cases. These are often combined with at-home warm compresses and eyelid hygiene.

Yes. Warm compresses applied to the closed eyelids for at least 10 minutes help soften inspissated (thickened) meibum so it can flow more freely. Gentle eyelid massage after warming can further improve gland secretion. This is a foundational part of MGD management regardless of whether prescription treatment is also used.

MGD is generally a chronic condition that requires ongoing management rather than a one-time cure. However, with consistent treatment including eyelid hygiene, warm compresses, and appropriate prescription therapy, most patients experience significant symptom relief and can maintain comfortable, stable eye health over the long term.

Doctronic uses an AI-guided evaluation to gather your symptom history and relevant medical information. A licensed physician then reviews your case, confirms whether MGD treatment is appropriate, and creates a personalized treatment plan. The entire process is designed to be thorough, convenient, and clinically sound.

Yes. Doctronic works only with licensed physicians who review every case individually. The platform is HIPAA-compliant, and all treatment decisions are doctor-reviewed and audited for safety. Doctronic is available to adults 18 and older in any U.S. state.